nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Atenolol—Procarbazine—hematologic cancer	0.363	1	CrCrCtD
Oxprenolol—SLC22A2—Daunorubicin—hematologic cancer	0.0704	0.156	CbGbCtD
Oxprenolol—SLC22A2—Cytarabine—hematologic cancer	0.0621	0.138	CbGbCtD
Oxprenolol—SLC22A2—Cladribine—hematologic cancer	0.0586	0.13	CbGbCtD
Oxprenolol—SLC22A2—Imatinib—hematologic cancer	0.0539	0.12	CbGbCtD
Oxprenolol—SLC22A2—Vinblastine—hematologic cancer	0.0299	0.0664	CbGbCtD
Oxprenolol—CYP2D6—Lomustine—hematologic cancer	0.028	0.0621	CbGbCtD
Oxprenolol—SLC22A2—Cisplatin—hematologic cancer	0.0275	0.0609	CbGbCtD
Oxprenolol—CYP2D6—Idarubicin—hematologic cancer	0.025	0.0554	CbGbCtD
Oxprenolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0212	0.0471	CbGbCtD
Oxprenolol—CYP2D6—Bortezomib—hematologic cancer	0.0185	0.0409	CbGbCtD
Oxprenolol—CYP2D6—Imatinib—hematologic cancer	0.0135	0.03	CbGbCtD
Oxprenolol—CYP2D6—Nilotinib—hematologic cancer	0.0123	0.0273	CbGbCtD
Oxprenolol—CYP2D6—Vinorelbine—hematologic cancer	0.0122	0.027	CbGbCtD
Oxprenolol—CYP2D6—Vinblastine—hematologic cancer	0.00751	0.0167	CbGbCtD
Oxprenolol—CYP2D6—Dexamethasone—hematologic cancer	0.00556	0.0123	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—hematologic cancer	0.00461	0.0102	CbGbCtD
Oxprenolol—Acebutolol—SLC22A1—hematologic cancer	0.000359	0.506	CrCbGaD
Oxprenolol—Dyspepsia—Alitretinoin—hematologic cancer	0.000141	0.000978	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vincristine—hematologic cancer	0.000141	0.000976	CcSEcCtD
Oxprenolol—Hypotension—Irinotecan—hematologic cancer	0.000141	0.000974	CcSEcCtD
Oxprenolol—Hypotension—Mitoxantrone—hematologic cancer	0.000141	0.000974	CcSEcCtD
Oxprenolol—Insomnia—Vincristine—hematologic cancer	0.00014	0.000968	CcSEcCtD
Oxprenolol—Nausea—Nilotinib—hematologic cancer	0.000139	0.000964	CcSEcCtD
Oxprenolol—Diarrhoea—Lenalidomide—hematologic cancer	0.000139	0.000963	CcSEcCtD
Oxprenolol—Nausea—Imatinib—hematologic cancer	0.000139	0.000959	CcSEcCtD
Oxprenolol—Fatigue—Alitretinoin—hematologic cancer	0.000139	0.000958	CcSEcCtD
Oxprenolol—Abdominal pain—Thiotepa—hematologic cancer	0.000138	0.000955	CcSEcCtD
Oxprenolol—Hypersensitivity—Bortezomib—hematologic cancer	0.000138	0.000954	CcSEcCtD
Oxprenolol—Headache—Vinblastine—hematologic cancer	0.000138	0.000953	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	0.000137	0.00095	CcSEcCtD
Oxprenolol—Diarrhoea—Hydroxyurea—hematologic cancer	0.000137	0.000949	CcSEcCtD
Oxprenolol—Hypotension—Gemcitabine—hematologic cancer	0.000137	0.000949	CcSEcCtD
Oxprenolol—Fatigue—Ifosfamide—hematologic cancer	0.000137	0.000947	CcSEcCtD
Oxprenolol—Hypersensitivity—Bleomycin—hematologic cancer	0.000137	0.000947	CcSEcCtD
Oxprenolol—Insomnia—Irinotecan—hematologic cancer	0.000136	0.000943	CcSEcCtD
Oxprenolol—Nausea—Cladribine—hematologic cancer	0.000136	0.000942	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—hematologic cancer	0.000136	0.000938	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—hematologic cancer	0.000136	0.000938	CcSEcCtD
Oxprenolol—Hypersensitivity—Vinorelbine—hematologic cancer	0.000135	0.000932	CcSEcCtD
Oxprenolol—Dizziness—Lenalidomide—hematologic cancer	0.000135	0.000931	CcSEcCtD
Oxprenolol—Asthenia—Bortezomib—hematologic cancer	0.000134	0.000929	CcSEcCtD
Oxprenolol—Thrombocytopenia—Cisplatin—hematologic cancer	0.000134	0.000927	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.000134	0.000925	CcSEcCtD
Oxprenolol—Abdominal pain—Thalidomide—hematologic cancer	0.000134	0.000923	CcSEcCtD
Oxprenolol—Fatigue—Vincristine—hematologic cancer	0.000133	0.000923	CcSEcCtD
Oxprenolol—Asthenia—Bleomycin—hematologic cancer	0.000133	0.000922	CcSEcCtD
Oxprenolol—Insomnia—Gemcitabine—hematologic cancer	0.000133	0.000919	CcSEcCtD
Oxprenolol—Dyspepsia—Irinotecan—hematologic cancer	0.000133	0.000918	CcSEcCtD
Oxprenolol—Dyspepsia—Mitoxantrone—hematologic cancer	0.000133	0.000918	CcSEcCtD
Oxprenolol—Dizziness—Hydroxyurea—hematologic cancer	0.000133	0.000918	CcSEcCtD
Oxprenolol—Pruritus—Bortezomib—hematologic cancer	0.000132	0.000916	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—hematologic cancer	0.000132	0.000915	CcSEcCtD
Oxprenolol—Hyperhidrosis—Cisplatin—hematologic cancer	0.000132	0.000915	CcSEcCtD
Oxprenolol—Pruritus—Bleomycin—hematologic cancer	0.000131	0.000909	CcSEcCtD
Oxprenolol—Asthenia—Vinorelbine—hematologic cancer	0.000131	0.000907	CcSEcCtD
Oxprenolol—Nausea—Vinblastine—hematologic cancer	0.000131	0.000904	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Epirubicin—hematologic cancer	0.000131	0.000903	CcSEcCtD
Oxprenolol—Fatigue—Mitoxantrone—hematologic cancer	0.00013	0.000899	CcSEcCtD
Oxprenolol—Fatigue—Irinotecan—hematologic cancer	0.00013	0.000899	CcSEcCtD
Oxprenolol—Pruritus—Vinorelbine—hematologic cancer	0.000129	0.000895	CcSEcCtD
Oxprenolol—Bradycardia—Prednisone—hematologic cancer	0.000129	0.000891	CcSEcCtD
Oxprenolol—Hypersensitivity—Thiotepa—hematologic cancer	0.000129	0.00089	CcSEcCtD
Oxprenolol—Abdominal pain—Carmustine—hematologic cancer	0.000128	0.000887	CcSEcCtD
Oxprenolol—Diarrhoea—Bortezomib—hematologic cancer	0.000128	0.000886	CcSEcCtD
Oxprenolol—Hypotension—Cisplatin—hematologic cancer	0.000128	0.000885	CcSEcCtD
Oxprenolol—Headache—Lenalidomide—hematologic cancer	0.000127	0.000882	CcSEcCtD
Oxprenolol—Abdominal pain—Alitretinoin—hematologic cancer	0.000127	0.000878	CcSEcCtD
Oxprenolol—Fatigue—Gemcitabine—hematologic cancer	0.000127	0.000876	CcSEcCtD
Oxprenolol—Headache—Hydroxyurea—hematologic cancer	0.000126	0.000869	CcSEcCtD
Oxprenolol—Abdominal pain—Ifosfamide—hematologic cancer	0.000126	0.000868	CcSEcCtD
Oxprenolol—Asthenia—Thiotepa—hematologic cancer	0.000125	0.000866	CcSEcCtD
Oxprenolol—Diarrhoea—Vinorelbine—hematologic cancer	0.000125	0.000865	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000125	0.000863	CcSEcCtD
Oxprenolol—Hypersensitivity—Thalidomide—hematologic cancer	0.000124	0.00086	CcSEcCtD
Oxprenolol—Nausea—Melphalan—hematologic cancer	0.000124	0.00086	CcSEcCtD
Oxprenolol—Dizziness—Bortezomib—hematologic cancer	0.000124	0.000856	CcSEcCtD
Oxprenolol—Pruritus—Thiotepa—hematologic cancer	0.000124	0.000854	CcSEcCtD
Oxprenolol—Thrombocytopenia—Etoposide—hematologic cancer	0.000123	0.000849	CcSEcCtD
Oxprenolol—Abdominal pain—Vincristine—hematologic cancer	0.000122	0.000846	CcSEcCtD
Oxprenolol—Hyperhidrosis—Etoposide—hematologic cancer	0.000121	0.000838	CcSEcCtD
Oxprenolol—Asthenia—Thalidomide—hematologic cancer	0.000121	0.000838	CcSEcCtD
Oxprenolol—Dizziness—Vinorelbine—hematologic cancer	0.000121	0.000836	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000121	0.000836	CcSEcCtD
Oxprenolol—Nausea—Lenalidomide—hematologic cancer	0.000121	0.000836	CcSEcCtD
Oxprenolol—Hyperhidrosis—Prednisolone—hematologic cancer	0.00012	0.000827	CcSEcCtD
Oxprenolol—Hypersensitivity—Carmustine—hematologic cancer	0.00012	0.000826	CcSEcCtD
Oxprenolol—Pruritus—Thalidomide—hematologic cancer	0.000119	0.000826	CcSEcCtD
Oxprenolol—Diarrhoea—Thiotepa—hematologic cancer	0.000119	0.000826	CcSEcCtD
Oxprenolol—Abdominal pain—Mitoxantrone—hematologic cancer	0.000119	0.000824	CcSEcCtD
Oxprenolol—Abdominal pain—Irinotecan—hematologic cancer	0.000119	0.000824	CcSEcCtD
Oxprenolol—Nausea—Hydroxyurea—hematologic cancer	0.000119	0.000824	CcSEcCtD
Oxprenolol—Hypersensitivity—Alitretinoin—hematologic cancer	0.000118	0.000819	CcSEcCtD
Oxprenolol—Headache—Bortezomib—hematologic cancer	0.000117	0.000811	CcSEcCtD
Oxprenolol—Hypotension—Etoposide—hematologic cancer	0.000117	0.00081	CcSEcCtD
Oxprenolol—Hypersensitivity—Ifosfamide—hematologic cancer	0.000117	0.000809	CcSEcCtD
Oxprenolol—Asthenia—Carmustine—hematologic cancer	0.000116	0.000805	CcSEcCtD
Oxprenolol—Diarrhoea—Thalidomide—hematologic cancer	0.000116	0.000799	CcSEcCtD
Oxprenolol—Dizziness—Thiotepa—hematologic cancer	0.000115	0.000798	CcSEcCtD
Oxprenolol—Asthenia—Alitretinoin—hematologic cancer	0.000115	0.000797	CcSEcCtD
Oxprenolol—Headache—Vinorelbine—hematologic cancer	0.000115	0.000792	CcSEcCtD
Oxprenolol—Hypersensitivity—Vincristine—hematologic cancer	0.000114	0.000789	CcSEcCtD
Oxprenolol—Asthenia—Ifosfamide—hematologic cancer	0.000114	0.000788	CcSEcCtD
Oxprenolol—Pruritus—Alitretinoin—hematologic cancer	0.000114	0.000786	CcSEcCtD
Oxprenolol—Atenolol—ABCB1—hematologic cancer	0.000113	0.16	CrCbGaD
Oxprenolol—Pruritus—Ifosfamide—hematologic cancer	0.000112	0.000777	CcSEcCtD
Oxprenolol—Insomnia—Prednisolone—hematologic cancer	0.000112	0.000774	CcSEcCtD
Oxprenolol—Dizziness—Thalidomide—hematologic cancer	0.000112	0.000772	CcSEcCtD
Oxprenolol—Nausea—Bortezomib—hematologic cancer	0.000111	0.000769	CcSEcCtD
Oxprenolol—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000111	0.000768	CcSEcCtD
Oxprenolol—Hypersensitivity—Irinotecan—hematologic cancer	0.000111	0.000768	CcSEcCtD
Oxprenolol—Asthenia—Vincristine—hematologic cancer	0.000111	0.000768	CcSEcCtD
Oxprenolol—Diarrhoea—Carmustine—hematologic cancer	0.000111	0.000767	CcSEcCtD
Oxprenolol—Nausea—Bleomycin—hematologic cancer	0.00011	0.000763	CcSEcCtD
Oxprenolol—Hyperhidrosis—Triamcinolone—hematologic cancer	0.00011	0.000761	CcSEcCtD
Oxprenolol—Diarrhoea—Alitretinoin—hematologic cancer	0.00011	0.00076	CcSEcCtD
Oxprenolol—Headache—Thiotepa—hematologic cancer	0.000109	0.000756	CcSEcCtD
Oxprenolol—Diarrhoea—Ifosfamide—hematologic cancer	0.000109	0.000751	CcSEcCtD
Oxprenolol—Nausea—Vinorelbine—hematologic cancer	0.000109	0.000751	CcSEcCtD
Oxprenolol—Asthenia—Irinotecan—hematologic cancer	0.000108	0.000748	CcSEcCtD
Oxprenolol—Asthenia—Mitoxantrone—hematologic cancer	0.000108	0.000748	CcSEcCtD
Oxprenolol—Fatigue—Etoposide—hematologic cancer	0.000108	0.000748	CcSEcCtD
Oxprenolol—Dizziness—Carmustine—hematologic cancer	0.000107	0.000742	CcSEcCtD
Oxprenolol—Dizziness—Alitretinoin—hematologic cancer	0.000106	0.000735	CcSEcCtD
Oxprenolol—Diarrhoea—Vincristine—hematologic cancer	0.000106	0.000733	CcSEcCtD
Oxprenolol—Headache—Thalidomide—hematologic cancer	0.000106	0.000732	CcSEcCtD
Oxprenolol—Asthenia—Gemcitabine—hematologic cancer	0.000105	0.000729	CcSEcCtD
Oxprenolol—Dizziness—Ifosfamide—hematologic cancer	0.000105	0.000726	CcSEcCtD
Oxprenolol—Acebutolol—ABCB1—hematologic cancer	0.000104	0.147	CrCbGaD
Oxprenolol—Pruritus—Gemcitabine—hematologic cancer	0.000104	0.000719	CcSEcCtD
Oxprenolol—Nausea—Thiotepa—hematologic cancer	0.000104	0.000717	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000104	0.000717	CcSEcCtD
Oxprenolol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000103	0.000713	CcSEcCtD
Oxprenolol—Diarrhoea—Irinotecan—hematologic cancer	0.000103	0.000713	CcSEcCtD
Oxprenolol—Insomnia—Triamcinolone—hematologic cancer	0.000103	0.000712	CcSEcCtD
Oxprenolol—Dizziness—Vincristine—hematologic cancer	0.000102	0.000708	CcSEcCtD
Oxprenolol—Headache—Carmustine—hematologic cancer	0.000102	0.000703	CcSEcCtD
Oxprenolol—Thrombocytopenia—Betamethasone—hematologic cancer	0.000101	0.000699	CcSEcCtD
Oxprenolol—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000101	0.000699	CcSEcCtD
Oxprenolol—Hypersensitivity—Cisplatin—hematologic cancer	0.000101	0.000698	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—hematologic cancer	0.000101	0.000697	CcSEcCtD
Oxprenolol—Headache—Alitretinoin—hematologic cancer	0.000101	0.000696	CcSEcCtD
Oxprenolol—Diarrhoea—Gemcitabine—hematologic cancer	0.000101	0.000695	CcSEcCtD
Oxprenolol—Nausea—Thalidomide—hematologic cancer	0.0001	0.000694	CcSEcCtD
Oxprenolol—Dyspepsia—Triamcinolone—hematologic cancer	0.0001	0.000693	CcSEcCtD
Oxprenolol—Hyperhidrosis—Dexamethasone—hematologic cancer	9.98e-05	0.00069	CcSEcCtD
Oxprenolol—Hyperhidrosis—Betamethasone—hematologic cancer	9.98e-05	0.00069	CcSEcCtD
Oxprenolol—Dizziness—Irinotecan—hematologic cancer	9.97e-05	0.00069	CcSEcCtD
Oxprenolol—Abdominal pain—Etoposide—hematologic cancer	9.92e-05	0.000686	CcSEcCtD
Oxprenolol—Asthenia—Cisplatin—hematologic cancer	9.82e-05	0.000679	CcSEcCtD
Oxprenolol—Fatigue—Triamcinolone—hematologic cancer	9.81e-05	0.000678	CcSEcCtD
Oxprenolol—Headache—Vincristine—hematologic cancer	9.7e-05	0.000671	CcSEcCtD
Oxprenolol—Hypotension—Dexamethasone—hematologic cancer	9.65e-05	0.000667	CcSEcCtD
Oxprenolol—Hypotension—Betamethasone—hematologic cancer	9.65e-05	0.000667	CcSEcCtD
Oxprenolol—Nausea—Carmustine—hematologic cancer	9.63e-05	0.000666	CcSEcCtD
Oxprenolol—Nausea—Alitretinoin—hematologic cancer	9.54e-05	0.00066	CcSEcCtD
Oxprenolol—Headache—Mitoxantrone—hematologic cancer	9.45e-05	0.000653	CcSEcCtD
Oxprenolol—Headache—Irinotecan—hematologic cancer	9.45e-05	0.000653	CcSEcCtD
Oxprenolol—Nausea—Ifosfamide—hematologic cancer	9.43e-05	0.000652	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	9.4e-05	0.00065	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	9.4e-05	0.00065	CcSEcCtD
Oxprenolol—Arthralgia—Prednisone—hematologic cancer	9.38e-05	0.000648	CcSEcCtD
Oxprenolol—Diarrhoea—Cisplatin—hematologic cancer	9.37e-05	0.000648	CcSEcCtD
Oxprenolol—Insomnia—Dexamethasone—hematologic cancer	9.34e-05	0.000646	CcSEcCtD
Oxprenolol—Insomnia—Betamethasone—hematologic cancer	9.34e-05	0.000646	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—hematologic cancer	9.32e-05	0.000645	CcSEcCtD
Oxprenolol—Hypersensitivity—Etoposide—hematologic cancer	9.24e-05	0.000639	CcSEcCtD
Oxprenolol—Headache—Gemcitabine—hematologic cancer	9.2e-05	0.000636	CcSEcCtD
Oxprenolol—Nausea—Vincristine—hematologic cancer	9.2e-05	0.000636	CcSEcCtD
Oxprenolol—Hypersensitivity—Prednisolone—hematologic cancer	9.11e-05	0.00063	CcSEcCtD
Oxprenolol—Dyspepsia—Betamethasone—hematologic cancer	9.09e-05	0.000628	CcSEcCtD
Oxprenolol—Dyspepsia—Dexamethasone—hematologic cancer	9.09e-05	0.000628	CcSEcCtD
Oxprenolol—Asthenia—Etoposide—hematologic cancer	9e-05	0.000622	CcSEcCtD
Oxprenolol—Nausea—Mitoxantrone—hematologic cancer	8.96e-05	0.000619	CcSEcCtD
Oxprenolol—Nausea—Irinotecan—hematologic cancer	8.96e-05	0.000619	CcSEcCtD
Oxprenolol—Fatigue—Dexamethasone—hematologic cancer	8.9e-05	0.000615	CcSEcCtD
Oxprenolol—Fatigue—Betamethasone—hematologic cancer	8.9e-05	0.000615	CcSEcCtD
Oxprenolol—Pruritus—Etoposide—hematologic cancer	8.87e-05	0.000614	CcSEcCtD
Oxprenolol—Metoprolol—ABCB1—hematologic cancer	8.81e-05	0.124	CrCbGaD
Oxprenolol—Nausea—Gemcitabine—hematologic cancer	8.73e-05	0.000603	CcSEcCtD
Oxprenolol—Hyperhidrosis—Prednisone—hematologic cancer	8.69e-05	0.000601	CcSEcCtD
Oxprenolol—Diarrhoea—Etoposide—hematologic cancer	8.58e-05	0.000593	CcSEcCtD
Oxprenolol—Hypersensitivity—Triamcinolone—hematologic cancer	8.38e-05	0.00058	CcSEcCtD
Oxprenolol—Dizziness—Etoposide—hematologic cancer	8.29e-05	0.000574	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.19e-05	0.000566	CcSEcCtD
Oxprenolol—Dizziness—Prednisolone—hematologic cancer	8.18e-05	0.000566	CcSEcCtD
Oxprenolol—Asthenia—Triamcinolone—hematologic cancer	8.16e-05	0.000564	CcSEcCtD
Oxprenolol—Abdominal pain—Dexamethasone—hematologic cancer	8.16e-05	0.000564	CcSEcCtD
Oxprenolol—Abdominal pain—Betamethasone—hematologic cancer	8.16e-05	0.000564	CcSEcCtD
Oxprenolol—Nausea—Cisplatin—hematologic cancer	8.13e-05	0.000562	CcSEcCtD
Oxprenolol—Insomnia—Prednisone—hematologic cancer	8.13e-05	0.000562	CcSEcCtD
Oxprenolol—Pruritus—Triamcinolone—hematologic cancer	8.05e-05	0.000557	CcSEcCtD
Oxprenolol—Dyspepsia—Prednisone—hematologic cancer	7.91e-05	0.000547	CcSEcCtD
Oxprenolol—Headache—Etoposide—hematologic cancer	7.86e-05	0.000543	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—hematologic cancer	7.84e-05	0.000542	CcSEcCtD
Oxprenolol—Fatigue—Prednisone—hematologic cancer	7.75e-05	0.000536	CcSEcCtD
Oxprenolol—Headache—Prednisolone—hematologic cancer	7.75e-05	0.000536	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—hematologic cancer	7.61e-05	0.000526	CcSEcCtD
Oxprenolol—Dizziness—Triamcinolone—hematologic cancer	7.52e-05	0.00052	CcSEcCtD
Oxprenolol—Nausea—Etoposide—hematologic cancer	7.45e-05	0.000515	CcSEcCtD
Oxprenolol—Asthenia—Dexamethasone—hematologic cancer	7.41e-05	0.000512	CcSEcCtD
Oxprenolol—Asthenia—Betamethasone—hematologic cancer	7.41e-05	0.000512	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—hematologic cancer	7.36e-05	0.000509	CcSEcCtD
Oxprenolol—Nausea—Prednisolone—hematologic cancer	7.35e-05	0.000508	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—hematologic cancer	7.33e-05	0.000507	CcSEcCtD
Oxprenolol—Pruritus—Dexamethasone—hematologic cancer	7.3e-05	0.000505	CcSEcCtD
Oxprenolol—Pruritus—Betamethasone—hematologic cancer	7.3e-05	0.000505	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—hematologic cancer	7.26e-05	0.000502	CcSEcCtD
Oxprenolol—Headache—Triamcinolone—hematologic cancer	7.13e-05	0.000493	CcSEcCtD
Oxprenolol—Abdominal pain—Prednisone—hematologic cancer	7.11e-05	0.000491	CcSEcCtD
Oxprenolol—Diarrhoea—Dexamethasone—hematologic cancer	7.06e-05	0.000488	CcSEcCtD
Oxprenolol—Diarrhoea—Betamethasone—hematologic cancer	7.06e-05	0.000488	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—hematologic cancer	7.04e-05	0.000487	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—hematologic cancer	7.02e-05	0.000485	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—hematologic cancer	6.88e-05	0.000476	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.85e-05	0.000473	CcSEcCtD
Oxprenolol—Dizziness—Betamethasone—hematologic cancer	6.83e-05	0.000472	CcSEcCtD
Oxprenolol—Dizziness—Dexamethasone—hematologic cancer	6.83e-05	0.000472	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—hematologic cancer	6.8e-05	0.00047	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—hematologic cancer	6.8e-05	0.00047	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—hematologic cancer	6.79e-05	0.000469	CcSEcCtD
Oxprenolol—Nausea—Triamcinolone—hematologic cancer	6.76e-05	0.000467	CcSEcCtD
Oxprenolol—Hypersensitivity—Prednisone—hematologic cancer	6.62e-05	0.000458	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—hematologic cancer	6.61e-05	0.000457	CcSEcCtD
Oxprenolol—Hypotension—Epirubicin—hematologic cancer	6.57e-05	0.000454	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—hematologic cancer	6.48e-05	0.000448	CcSEcCtD
Oxprenolol—Headache—Dexamethasone—hematologic cancer	6.47e-05	0.000447	CcSEcCtD
Oxprenolol—Headache—Betamethasone—hematologic cancer	6.47e-05	0.000447	CcSEcCtD
Oxprenolol—Asthenia—Prednisone—hematologic cancer	6.45e-05	0.000446	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.41e-05	0.000443	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—hematologic cancer	6.37e-05	0.00044	CcSEcCtD
Oxprenolol—Pruritus—Prednisone—hematologic cancer	6.36e-05	0.00044	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—hematologic cancer	6.36e-05	0.00044	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—hematologic cancer	6.29e-05	0.000435	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—hematologic cancer	6.19e-05	0.000428	CcSEcCtD
Oxprenolol—Diarrhoea—Prednisone—hematologic cancer	6.15e-05	0.000425	CcSEcCtD
Oxprenolol—Nausea—Dexamethasone—hematologic cancer	6.13e-05	0.000424	CcSEcCtD
Oxprenolol—Nausea—Betamethasone—hematologic cancer	6.13e-05	0.000424	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—hematologic cancer	6.08e-05	0.00042	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—hematologic cancer	6.06e-05	0.000419	CcSEcCtD
Oxprenolol—Dizziness—Prednisone—hematologic cancer	5.94e-05	0.000411	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—hematologic cancer	5.94e-05	0.000411	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.93e-05	0.00041	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—hematologic cancer	5.88e-05	0.000407	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—hematologic cancer	5.73e-05	0.000396	CcSEcCtD
Oxprenolol—Headache—Prednisone—hematologic cancer	5.63e-05	0.000389	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—hematologic cancer	5.61e-05	0.000388	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—hematologic cancer	5.56e-05	0.000384	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—hematologic cancer	5.54e-05	0.000383	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—hematologic cancer	5.39e-05	0.000373	CcSEcCtD
Oxprenolol—Nausea—Prednisone—hematologic cancer	5.34e-05	0.000369	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—hematologic cancer	5.32e-05	0.000368	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—hematologic cancer	5.18e-05	0.000358	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—hematologic cancer	5.14e-05	0.000356	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—hematologic cancer	5.14e-05	0.000355	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—hematologic cancer	5.04e-05	0.000349	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—hematologic cancer	4.97e-05	0.000344	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—hematologic cancer	4.97e-05	0.000344	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—hematologic cancer	4.81e-05	0.000333	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—hematologic cancer	4.79e-05	0.000331	CcSEcCtD
Oxprenolol—Headache—Methotrexate—hematologic cancer	4.71e-05	0.000325	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—hematologic cancer	4.67e-05	0.000323	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—hematologic cancer	4.65e-05	0.000322	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—hematologic cancer	4.6e-05	0.000318	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—hematologic cancer	4.46e-05	0.000309	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—hematologic cancer	4.45e-05	0.000308	CcSEcCtD
Oxprenolol—Propranolol—ABCB1—hematologic cancer	4.45e-05	0.0627	CrCbGaD
Oxprenolol—Headache—Epirubicin—hematologic cancer	4.4e-05	0.000305	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—hematologic cancer	4.3e-05	0.000297	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—hematologic cancer	4.18e-05	0.000289	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—hematologic cancer	4.08e-05	0.000282	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—hematologic cancer	3.86e-05	0.000267	CcSEcCtD
Oxprenolol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	9.96e-06	0.000242	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CBL—hematologic cancer	9.92e-06	0.000241	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA9—hematologic cancer	9.84e-06	0.000239	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ACP5—hematologic cancer	9.84e-06	0.000239	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL3—hematologic cancer	9.81e-06	0.000239	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOR2—hematologic cancer	9.71e-06	0.000236	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CBL—hematologic cancer	9.7e-06	0.000236	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	9.7e-06	0.000236	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	9.65e-06	0.000235	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL3—hematologic cancer	9.6e-06	0.000234	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—hematologic cancer	9.55e-06	0.000232	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	9.53e-06	0.000232	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	9.49e-06	0.000231	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	9.48e-06	0.000231	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SYK—hematologic cancer	9.46e-06	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	9.46e-06	0.00023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	9.44e-06	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	9.39e-06	0.000228	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	9.32e-06	0.000227	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	9.29e-06	0.000226	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SYK—hematologic cancer	9.26e-06	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	9.26e-06	0.000225	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—IDH1—hematologic cancer	9.25e-06	0.000225	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	9.23e-06	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	9.18e-06	0.000223	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.15e-06	0.000223	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.15e-06	0.000223	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TXN—hematologic cancer	9.15e-06	0.000223	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	9.12e-06	0.000222	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—hematologic cancer	9.04e-06	0.00022	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	9.03e-06	0.00022	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	9.03e-06	0.00022	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	9e-06	0.000219	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.95e-06	0.000218	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	8.93e-06	0.000217	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	8.86e-06	0.000216	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	8.83e-06	0.000215	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	8.81e-06	0.000214	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—hematologic cancer	8.78e-06	0.000214	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NCOR1—hematologic cancer	8.78e-06	0.000214	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	8.67e-06	0.000211	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	8.61e-06	0.00021	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.6e-06	0.000209	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	8.58e-06	0.000209	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	8.54e-06	0.000208	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	8.52e-06	0.000207	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	8.52e-06	0.000207	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	8.43e-06	0.000205	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	8.39e-06	0.000204	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	8.39e-06	0.000204	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.37e-06	0.000204	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.37e-06	0.000204	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	8.35e-06	0.000203	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	8.34e-06	0.000203	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	8.33e-06	0.000203	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	8.21e-06	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	8.2e-06	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	8.18e-06	0.000199	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.16e-06	0.000198	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	8.13e-06	0.000198	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	8.05e-06	0.000196	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	8.03e-06	0.000195	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	8e-06	0.000195	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	7.96e-06	0.000194	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NUP98—hematologic cancer	7.9e-06	0.000192	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	7.87e-06	0.000192	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	7.87e-06	0.000191	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	7.82e-06	0.00019	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	7.76e-06	0.000189	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—hematologic cancer	7.76e-06	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	7.71e-06	0.000188	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	7.69e-06	0.000187	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.67e-06	0.000187	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.67e-06	0.000187	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	7.65e-06	0.000186	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	7.63e-06	0.000186	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	7.63e-06	0.000186	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NUP214—hematologic cancer	7.61e-06	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	7.59e-06	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	7.55e-06	0.000184	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	7.52e-06	0.000183	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	7.51e-06	0.000183	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	7.5e-06	0.000183	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	7.46e-06	0.000182	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	7.46e-06	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.46e-06	0.000181	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTR—hematologic cancer	7.46e-06	0.000181	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	7.43e-06	0.000181	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	7.39e-06	0.00018	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	7.36e-06	0.000179	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	7.36e-06	0.000179	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	7.35e-06	0.000179	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	7.35e-06	0.000179	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	7.34e-06	0.000179	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO2—hematologic cancer	7.32e-06	0.000178	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	7.27e-06	0.000177	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	7.23e-06	0.000176	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	7.2e-06	0.000175	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	7.2e-06	0.000175	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.1e-06	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDC1—hematologic cancer	6.93e-06	0.000169	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	6.88e-06	0.000167	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	6.82e-06	0.000166	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	6.8e-06	0.000165	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	6.73e-06	0.000164	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	6.67e-06	0.000162	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	6.65e-06	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	6.64e-06	0.000161	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—hematologic cancer	6.52e-06	0.000159	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	6.49e-06	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	6.49e-06	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	6.34e-06	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	6.24e-06	0.000152	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	6.18e-06	0.00015	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	6.1e-06	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	6.06e-06	0.000147	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CREBBP—hematologic cancer	6.04e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	6.04e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	5.99e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	5.93e-06	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	5.91e-06	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	5.91e-06	0.000144	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NQO1—hematologic cancer	5.9e-06	0.000143	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD44—hematologic cancer	5.9e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	5.86e-06	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	5.85e-06	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	5.79e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	5.79e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	5.74e-06	0.00014	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—hematologic cancer	5.66e-06	0.000138	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	5.63e-06	0.000137	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	5.61e-06	0.000137	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	5.6e-06	0.000136	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	5.6e-06	0.000136	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	5.6e-06	0.000136	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYCS—hematologic cancer	5.58e-06	0.000136	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.54e-06	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	5.5e-06	0.000134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	5.49e-06	0.000133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	5.45e-06	0.000133	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3R1—hematologic cancer	5.41e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	5.38e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	5.37e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	5.33e-06	0.00013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	5.33e-06	0.00013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	5.32e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	5.31e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	5.27e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	5.22e-06	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	5.2e-06	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	5.19e-06	0.000126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	5.07e-06	0.000123	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	5.04e-06	0.000122	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—hematologic cancer	4.99e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.99e-06	0.000121	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	4.96e-06	0.000121	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	4.93e-06	0.00012	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	4.93e-06	0.00012	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.92e-06	0.00012	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.88e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	4.82e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	4.82e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	4.75e-06	0.000116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	4.72e-06	0.000115	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	4.65e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	4.62e-06	0.000112	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	4.53e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	4.52e-06	0.00011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.52e-06	0.00011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.52e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	4.51e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	4.43e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	4.41e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	4.39e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	4.39e-06	0.000107	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTEN—hematologic cancer	4.32e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	4.29e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	4.29e-06	0.000104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	4.19e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	4.12e-06	0.0001	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—EP300—hematologic cancer	4.12e-06	0.0001	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	4.1e-06	9.97e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	4.07e-06	9.91e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	4.04e-06	9.82e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	4.03e-06	9.81e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	4.03e-06	9.8e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	4.01e-06	9.76e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.99e-06	9.72e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	3.99e-06	9.7e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	3.95e-06	9.61e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	3.94e-06	9.59e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	3.93e-06	9.56e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	3.92e-06	9.54e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	3.92e-06	9.54e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	3.84e-06	9.35e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	3.84e-06	9.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	3.8e-06	9.25e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	3.79e-06	9.23e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	3.72e-06	9.05e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	3.71e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	3.71e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	3.7e-06	9e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	3.63e-06	8.83e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	3.62e-06	8.8e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	3.62e-06	8.8e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	3.54e-06	8.61e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	3.52e-06	8.56e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	3.44e-06	8.37e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	3.43e-06	8.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	3.39e-06	8.25e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	3.38e-06	8.23e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.36e-06	8.16e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	3.35e-06	8.15e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	3.32e-06	8.07e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	3.31e-06	8.05e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	3.24e-06	7.88e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	3.17e-06	7.71e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	3.15e-06	7.67e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	3.14e-06	7.65e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.11e-06	7.57e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	3.08e-06	7.5e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	3.08e-06	7.48e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—hematologic cancer	3.04e-06	7.41e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.95e-06	7.18e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	2.91e-06	7.08e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—hematologic cancer	2.91e-06	7.08e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	2.85e-06	6.93e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.79e-06	6.78e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	2.68e-06	6.51e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	2.62e-06	6.37e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	2.59e-06	6.3e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.57e-06	6.26e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	2.53e-06	6.16e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—hematologic cancer	2.49e-06	6.05e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	2.48e-06	6.02e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	2.42e-06	5.89e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	2.37e-06	5.76e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	2.32e-06	5.64e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTEN—hematologic cancer	2.22e-06	5.41e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.19e-06	5.32e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.14e-06	5.2e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—EP300—hematologic cancer	2.12e-06	5.15e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.57e-06	3.81e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—hematologic cancer	1.28e-06	3.12e-05	CbGpPWpGaD
